Diallyl Biphenyl-Type Neolignans Have a Pharmacophore of PPARα/γ Dual Modulators |
Han, Yujia
(College of Pharmacy and Natural Products Research Institute, Seoul National University)
Liu, Jingjing (College of Pharmacy and Natural Products Research Institute, Seoul National University) Ahn, Sungjin (College of Pharmacy and Natural Products Research Institute, Seoul National University) An, Seungchan (College of Pharmacy and Natural Products Research Institute, Seoul National University) Ko, Hyejin (College of Pharmacy and Natural Products Research Institute, Seoul National University) Shin, Jeayoung C. (College of Pharmacy and Natural Products Research Institute, Seoul National University) Jin, Sun Hee (College of Pharmacy and Natural Products Research Institute, Seoul National University) Ki, Min Won (College of Pharmacy and Natural Products Research Institute, Seoul National University) Lee, So Hun (SK Bioland) Lee, Kang Hyuk (SK Bioland) Shin, Song Seok (SK Bioland) Choi, Won Jun (College of Pharmacy, Dongguk University) Noh, Minsoo (College of Pharmacy and Natural Products Research Institute, Seoul National University) |
1 |
Kim, S. O., Han, Y., Ahn, S., An, S., Shin, J. C., Choi, H., Kim, H. J., Park, N. H., Kim, Y. J., Jin, S. H., Rho, H. S. and Noh, M. (2018) Kojylcinnamate esters are peroxisome proliferator-activated receptor |
2 |
Lefterova, M. I., Haakonsson, A. K., Lazar, M. A. and Mandrup, S. (2014) |
3 | Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M. and Kliewer, S. A. (1997) Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272, 3406-3410. DOI |
4 | Liang, X., Xing, W., He, J., Fu, F., Zhang, W., Su, F., Liu, F., Ji, L., Gao, F., Su, H., Sun, X. and Zhang, H. (2015) Magnolol administration in normotensive young spontaneously hypertensive rats postpones the development of hypertension: role of increased PPAR gamma, reduced TRB3 and resultant alleviative vascular insulin resistance. PLoS ONE 10, e0120366. DOI |
5 | Fukuen, S., Iwaki, M., Yasui, A., Makishima, M., Matsuda, M. and Shimomura, L. (2005) Sulfonylurea agents exhibit peroxisome proliferator-activated receptor gamma agonistic activity. J. Biol. Chem. 280, 23653-23659. DOI |
6 |
Garcia-Vallve, S., Guasch, L., Tomas-Hernandez, S., del Bas, J. M., Ollendorff, V., Arola, L., Pujadas, G. and Mulero, M. (2015) Peroxisome proliferator-activated receptor |
7 |
Hughes, T. S., Giri, P. K., de Vera, I. M., Marciano, D. P., Kuruvilla, D. S., Shin, Y., Blayo, A. L., Kamenecka, T. M., Burris, T. P., Griffin, P. R. and Kojetin, D. J. (2014) An alternate binding site for |
8 | Gross, B., Pawlak, M., Lefebvre, P. and Staels, B. (2017) PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat. Rev. Endocrinol. 13, 36-49. DOI |
9 |
Henry, R. R., Lincoff, A. M., Mudaliar, S., Rabbia, M., Chognot, C. and Herz, M. (2009) Effect of the dual peroxisome proliferator-activated |
10 | Home, P. (2011) Safety of PPAR agonists. Diabetes Care 34, S215-S219. DOI |
11 | Iwaki, M., Matsuda, M., Maeda, N., Funahashi, T., Matsuzawa, Y., Makishima, M. and Shimomura, I. (2003) Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52, 1655-1663. DOI |
12 |
Wang, L., Waltenberger, B., Pferschy-Wenzig, E. M., Blunder, M., Liu, X., Malainer, C., Schuster, D., Blazevic, T., Schwaiger, S., Rollinger, J. M., Heiss, E. H., Schuster, D., Kopp, B., Bauer, R., Stuppner, H., Dirsch, V. M. and Atanasov, A. G. (2014) Natural product agonists of peroxisome proliferator-activated receptor gamma ( |
13 | Lincoff, A. M., Tardif, J. C., Schwartz, G. G., Nicholls, S. J., Ryden, L., Neal, B., Malmberg, K., Wedel, H., Buse, J. B., Henry, R. R., Weichert, A., Cannata, R., Svensson, A., Volz, D. and Grobbee, D. E. (2014) Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial. JAMA 311, 1515-1525. DOI |
14 | Noh, M. (2012) Interleukin-17A increases leptin production in human bone marrow mesenchymal stem cells. Biochem. Pharmacol. 83, 661-670. DOI |
15 | Pfaffl, M. W., Horgan, G. W. and Dempfle, L. (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30, e36. DOI |
16 | Shin, D. W., Kim, S. N., Lee, S. M., Lee, W., Song, M. J., Park, S. M., Lee, T. R., Baik, J. H., Kim, H. K., Hong, J. H. and Noh, M. (2009) (-)-Catechin promotes adipocyte differentiation in human bone marrow mesenchymal stem cells through PPAR gamma transactivation. Biochem. Pharmacol. 77, 125-133. DOI |
17 | Straub, L. G. and Scherer, P. E. (2019) Metabolic messengers: adiponectin. Nat. Metab. 1, 334-339. DOI |
18 | Waragai, M., Ho, G., Takamatsu, Y., Shimizu, Y., Sugino, H., Sugama, S., Takenouchi, T., Masliah, E. and Hashimoto, M. (2018) Dual-therapy strategy for modification of adiponectin receptor signaling in aging-associated chronic diseases. Drug Discov. Today 23, 1305-1311. DOI |
19 | Xu, H. E., Stanley, T. B., Montana, V. G., Lambert, M. H., Shearer, B. G., Cobb, J. E., McKee, D. D., Galardi, C. M., Plunket, K. D., Nolte, R. T., Parks, D. J., Moore, J. T., Kliewer, S. A., Willson, T. M. and Stimmel, J. B. (2002) Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature 415, 813-817. DOI |
20 | Xu, H. E., Lambert, M. H., Montana, V. G., Parks, D. J., Blanchard, S. G., Brown, P. J., Sternbach, D. D., Lehmann, J. M., Wisely, G. B., Willson, T. M., Kliewer, S. A. and Milburn, M. V. (1999) Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol. Cell 3, 397-403. DOI |
21 | Yamauchi, T. and Kadowaki, T. (2008) Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int. J. Obes. (Lond.) 32, S13-S18. |
22 | Yamauchi, T., Kamonm, J., Minokoshi, Y. A., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., Eto, K., Akanuma, Y., Froguel, P., Foufelle, F., Ferre, P., Carling, D., Kimura, S., Nagai, R., Kahn, B. B. and Kadowaki, T. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288-1295. DOI |
23 |
Yu, J., Ahn, S., Kim, H. J., Lee, M., Ahn, S., Kim, J., Jin, S. H., Lee, E., Kim, G., Cheong, J. H., Jacobson, K. A., Jeong, L. S. and Noh, M. (2017) Polypharmacology of N6-(3-Iodobenzyl) adenosine-5′-N-methyluronamide (IB-MECA) and related A3 adenosine receptor ligands: peroxisome proliferator activated receptor (PPAR) |
24 |
Zhang, H., Xu, X., Chen, L., Chen, J., Hu, L., Jiang, H. and Shen, X. (2011) Molecular determinants of magnolol targeting both |
25 | Chakrabarti, P. (2010) Promoting adipose specificity: the adiponectin promoter. Endocrinology 151, 2408-2410. DOI |
26 |
Ahn, S., Lee, M., An, S., Hyun, S., Hwang, J., Lee, J. and Noh, M. (2018) 2-Formyl-komarovicine promotes adiponectin production in human mesenchymal stem cells through |
27 | Trott, O. and Olson, A. J. (2010) AutoDockVina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455-461. |
28 |
Atanasov, A. G., Wang, J. N., Gu, S. P., Bu, J., Kramer, M. P., Baumgartner, L., Fakhrudin, N., Ladurner, A., Malainer, C., Vuorinen, A., Noha, S. M, Schwaiger, S., Rollinger, J. M., Schuster, D., Stuppner, H., Dirsch, V. M. and Heiss, E. H. (2013) Honokiol: a non- |
29 |
Bernardes, A., Souza, P. C., Muniz, J. R., Ricci, C. G., Ayers, S. D., Parekh, N. M., Godoy, A. S., Trivella, D. B., Reinach, P., Webb, P., Skaf, M. S. and Polikarpov, I. (2013) Molecular mechanism of peroxisome proliferator-activated receptor |
30 | Byun, Y., Park, J., Hong, S. H., Han, M. H., Park, S., Jung, H. and Noh, M. (2013) The opposite effect of isotype-selective monoamine oxidase inhibitors on adipogenesis in human bone marrow mesenchymal stem cells. Bioorg. Med. Chem. Lett. 23, 3273-3276. DOI |
31 | Farmer, S. R. (2005) Regulation of PPARgamma activity during adipogenesis. Int. J. Obes. 29, S13-S16. DOI |
32 | Chen, Q., Shou. P., Zheng, C., Jiang, M., Cao, G., Yang, Q., Cao, J., Xie, N., Velletri, T., Zhang, X., Xu, C., Zhang, L., Yang, H., Hou, J., Wang, Y. and Shi, Y. (2016) Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ. 23, 1128-1139. DOI |
33 | Dalamaga, M., Diakopoulos, K. N. and Mantzoros, C. S. (2012) The role of adiponectin in cancer: a review of current evidence. Endocr. Rev. 33, 547-594. DOI |
34 | Erickson, J. A., Jalaie, M., Robertson, D. H., Lewis, R. A. and Vieth, M. (2004) Lessons in molecular recognition: the effects of ligand and protein flexibility on molecular docking accuracy. J. Med. Chem. 47, 45-55. DOI |
35 | Kershaw, E. E. and Flier, J. S. (2004) Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89, 2548-2556. DOI |
36 |
Jain, M. R., Giri, S. R., Bhoi, B., Trivedi, C., Rath, A., Rathod, R., Ranvir, R., Kadam, S., Patel, H., Swain, P., Roy, S. S., Das, N., Karmakar, E., Wahli, W. and Patel, P. R. (2018) Dual |
![]() |